Vimarsana
Biggest News Aggregation in the World

Page 3 - Jack Cox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jack Cox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jack Cox Today - Breaking & Trending Today

Nevada high school baseball, softball, boys volleyball scores April 11, 2024 - Vimarsana News

Nevada high school baseball, softball, boys volleyball scores April 11, 2024

Check out the scores and top performances from Thursday’s high school baseball, softball and boys volleyball action.

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA - Vimarsana News

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA

/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...

Biogen's QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP -February 23, 2024 at 07:01 am EST - Vimarsana News

Biogen's QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP -February 23, 2024 at 07:01 am EST

SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1With QALSODY, Biogen has advanced the role of neurofilament in the development...

Dallas' Child, Adult Care Facilities Get a Boost from City Council - Vimarsana News

Dallas' Child, Adult Care Facilities Get a Boost from City Council

Now, Dallas child and adult care facilities can open up in more areas of the city than before.

Biogen to Realign Resources for Alzheimer's Disease Franchise - Vimarsana News

Biogen to Realign Resources for Alzheimer's Disease Franchise

Company to reprioritize resources allocated to ADUHELM® (aducanumab-avwa) to advance LEQEMBI® (lecanemab-irmb) and to develop new treatment modali...